EQA Catalogue Groups
(Click on a colour to filter calendar entries)
Sample Handling
Technical (NGS and OGM)
Preimplantation Genetic Testing (PGT)
Reproductive Genomics
Molecular Newborn Screening
Genomic and Inherited Disorders
Pharmacogenomics
Haematological Neoplasms
Molecular Pathology
Variant Classification
Clinical Genetics and Genetic Counselling
Viral Sequencing
Other Events
GenQA EQA Enrolment Event
GenQA EQA Distribution Event
GenQA webinar
Individual Competency Assessment
Conference
GenQA Participant workshop
GenQA Participant meeting
GenQA office closed
Other
«prev June 2023 next»
| ||||||
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
Sun 28 | Mon 29 | Tue 30 | Wed 31 The webinar will reveiw the GenQA pre-analytical EQAs and the importance of these EQAs for downstream processing of samples. | Thu 1 | Fri 2 | Sat 3 |
Sun 4 | Mon 5
Distribution 8 OPEN
2023 DNA extraction from venous blood - OPENS Testing Period: 3 Weeks | Tue 6 | Wed 7 | Thu 8 | Fri 9
2023 Chromosome Breakage syndromes - CLOSES
2023 Disorders of Sex Development (DSD) - CLOSES
2023 Hypotonic Infant - CLOSES
2023 Imprinting disorders - CLOSES
2023 Infertility - CLOSES
2023 Severe Developmental Delay - CLOSES
2023 X-Inactivation - CLOSES
2023 Abnormal ultrasound - CLOSES | Sat 10 Workshops, posters and new developments! |
Sun 11 Workshops, posters and new developments! | Mon 12 Workshops, posters and new developments!
Distribution 9 OPEN
2023 Calcium disorders - OPENS Testing Period: 12 weeks
2023 Cardiac Disorders - OPENS Testing Period: 12 weeks
2023 Charcot Marie Tooth disease (CMT) and related sensory and motor neuropathies - OPENS Testing Period: 12 weeks
2023 Familial endocrine tumour predisposition disorders - OPENS Testing Period: 12 weeks
2023 Familial Hypercholesterolaemia (FH) - OPENS Testing Period: 12 weeks
2023 Fragile X syndrome and FMR1-related disorders - OPENS Testing Period: 12 weeks
2023 Huntington disease (HD) and DRPLA - OPENS Testing Period: 12 weeks
2023 Linkage analysis - OPENS Testing Period: 12 weeks
2023 Mitochondrial disease - OPENS Testing Period: 12 weeks
2023 Neurofibromatosis and Rasopathies - OPENS Testing Period: 12 weeks
2023 Skeletal Dysplasia (including Osteogenesis Imperfecta) - OPENS Testing Period: 12 weeks
2023 Exome Sequencing - OPENS Testing Period: 17 weeks
2023 Maternal cell contamination (MCC) & sexing - OPENS Testing Period: 12 weeks | Tue 13 Workshops, posters and new developments! | Wed 14 | Thu 15 | Fri 16 | Sat 17 |
Sun 18 | Mon 19 | Tue 20 | Wed 21 | Thu 22 | Fri 23
2023 Clinical Genetics - Dysmorphology - CLOSES
2023 Genetic Counselling (pilot) - CLOSES
2023 Acute Lymphoblastic Leukaemia (ALL) - CLOSES
2023 Haematological Technical FISH - CLOSES
2023 Myeloid disorders - CLOSES
2023 Myeloma - CLOSES
2023 Microdeletion syndromes - CLOSES
2023 Postnatal karyotyping - CLOSES
2023 DNA extraction from venous blood - CLOSES | Sat 24 |
Sun 25 | Mon 26
Distribution 10 OPEN
2023 Cystic Fibrosis (CF) Molecular Newborn screening (bloodspots) round 2 Round 1 - OPENS Testing Period: 4 weeks
2023 MCADD Molecular Newborn Screening (bloodspots) round 2 - OPENS Testing Period: 4 weeks
2023 SCID Molecular Newborn Screening (bloodspots) round 2 - OPENS Testing Period: 4 weeks | Tue 27
Distribution 11 OPEN
2023 DNA extraction from fresh frozen (FF) tissue - OPENS Testing Period: 3 weeks | Wed 28 | Thu 29 | Fri 30
2023 ISCN (International System for Human Cytogenomic Nomenclature) (Classification only) (pilot) - CLOSES | Sat 1 |
NEWSLETTER SIGN UP